Four patients of the other group (two EBV+ CD56 negative TNKCL, one indolent TLPD and one ALCL) (57%), one MEITL (11%), and three ATLL (27%) patients showed ulcerative type lesions. This evidence concerns the gene NCAM1 and adult T-cell leukemia/lymphoma.